A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.
Once those prices are set, most large government programs that cover prescription drugs pay prices that are tied to ...
ChemDiv, a global provider of integrated drug discovery solutions, today announced the extension of its Chemistry, Manufacturing and Controls (CMC) services collaboration supporting the clinical ...
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...
Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard ...
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class ...
SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback